These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28173755)

  • 1. Melanoma genome evolution across species.
    Kansler ER; Verma A; Langdon EM; Simon-Vermot T; Yin A; Lee W; Attiyeh M; Elemento O; White RM
    BMC Genomics; 2017 Feb; 18(1):136. PubMed ID: 28173755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models.
    Yen J; White RM; Wedge DC; Van Loo P; de Ridder J; Capper A; Richardson J; Jones D; Raine K; Watson IR; Wu CJ; Cheng J; Martincorena I; Nik-Zainal S; Mudie L; Moreau Y; Marshall J; Ramakrishna M; Tarpey P; Shlien A; Whitmore I; Gamble S; Latimer C; Langdon E; Kaufman C; Dovey M; Taylor A; Menzies A; McLaren S; O'Meara S; Butler A; Teague J; Lister J; Chin L; Campbell P; Adams DJ; Zon LI; Patton EE; Stemple DL; Futreal PA
    Genome Biol; 2013; 14(10):R113. PubMed ID: 24148783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression.
    Romano E; Pradervand S; Paillusson A; Weber J; Harshman K; Muehlethaler K; Speiser D; Peters S; Rimoldi D; Michielin O
    Clin Cancer Res; 2013 Oct; 19(20):5749-57. PubMed ID: 23948972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
    Guo X; Xu Y; Zhao Z
    Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vemurafenib in patients with BRAF V600E mutation-positive advanced melanoma.
    Ravnan MC; Matalka MS
    Clin Ther; 2012 Jul; 34(7):1474-86. PubMed ID: 22742884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
    Mishra PJ; Mishra PJ; Merlino G
    PLoS One; 2016; 11(11):e0165102. PubMed ID: 27846237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
    Lázár V
    Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
    Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genetic Evolution of Melanoma from Precursor Lesions.
    Shain AH; Yeh I; Kovalyshyn I; Sriharan A; Talevich E; Gagnon A; Dummer R; North J; Pincus L; Ruben B; Rickaby W; D'Arrigo C; Robson A; Bastian BC
    N Engl J Med; 2015 Nov; 373(20):1926-36. PubMed ID: 26559571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting Oncogenic RAS Signaling in Melanoma Development in Genetically Engineered Zebrafish Models.
    Badrock AP; Hurlstone A
    Methods Mol Biol; 2021; 2262():411-422. PubMed ID: 33977492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Approaches to Zebrafish Cancer.
    White RM
    Adv Exp Med Biol; 2016; 916():125-45. PubMed ID: 27165352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma.
    Kim A; Cohen MS
    Expert Opin Drug Discov; 2016 Sep; 11(9):907-16. PubMed ID: 27327499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct sets of genetic alterations in melanoma.
    Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
    N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib.
    Hoogstraat M; Gadellaa-van Hooijdonk CG; Ubink I; Besselink NJ; Pieterse M; Veldhuis W; van Stralen M; Meijer EF; Willems SM; Hadders MA; Kuilman T; Krijgsman O; Peeper DS; Koudijs MJ; Cuppen E; Voest EE; Lolkema MP
    Pigment Cell Melanoma Res; 2015 May; 28(3):318-23. PubMed ID: 25515853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic progression of malignant melanoma.
    Tímár J; Vizkeleti L; Doma V; Barbai T; Rásó E
    Cancer Metastasis Rev; 2016 Mar; 35(1):93-107. PubMed ID: 26970965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
    Garraway LA; Widlund HR; Rubin MA; Getz G; Berger AJ; Ramaswamy S; Beroukhim R; Milner DA; Granter SR; Du J; Lee C; Wagner SN; Li C; Golub TR; Rimm DL; Meyerson ML; Fisher DE; Sellers WR
    Nature; 2005 Jul; 436(7047):117-22. PubMed ID: 16001072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering Melanoma Cell States and Plasticity with Zebrafish Models.
    Travnickova J; Patton EE
    J Invest Dermatol; 2021 Jun; 141(6):1389-1394. PubMed ID: 33340501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.
    Miao B; Ji Z; Tan L; Taylor M; Zhang J; Choi HG; Frederick DT; Kumar R; Wargo JA; Flaherty KT; Gray NS; Tsao H
    Cancer Discov; 2015 Mar; 5(3):274-87. PubMed ID: 25542448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF V600E-dependent role of autophagy in uveal melanoma.
    Zhao Y; Wang W; Min I; Wyrwas B; Moore M; Zarnegar R; Fahey TJ
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):447-455. PubMed ID: 27928645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.